From Wikipedia, the free encyclopedia
SIGN Fracture Care
SIGN Fracture Care International
NicknameSIGN
FoundedJanuary 29, 1999; 25 years ago (1999-01-29)
FounderDr. Lewis G. Zirkle, Jr., President
Type Non-Profit Organization
501(c)(3)
91-1952283
PurposeBuilding orthopaedic capacity in LMIC by providing orthopaedic education and medical device design, manufacture, and donation of implants.
HeadquartersRichland, Washington, U.S.
Region
Global
Chief Executive Officer
Jeanne Dillner
Budget (2022)
US$ 8,340,000
Revenue (2022)
US$ 7,838,000
Expenses (2022)US$ 8,534,000
Staff (2023)
41
Website https://signfracturecare.org
Formerly called
Surgical Implant Generation Network

Overview

SIGN Fracture Care (SIGN) is a 501(c)(3) non-profit organization equipping orthopaedic surgeons in low-and middle-income countries (LMIC). It was founded in 1999 by Dr. Lewis G. Zirkle, Jr. to help surgeons care for patients with a fractured long bone.

SIGN’s vision is to create equality of fracture care throughout the world. [1]

SIGN empowers doctors in impoverished countries to improve the quality of care they can provide for patients with bone fractures. The SIGN Model is to provide ongoing educational support for LMIC surgeons, then donate the orthopaedic instruments and implants the surgeons need to care for patients with broken bones.

SIGN’s founder invented and patented a system of orthopaedic instruments and implants designed for use in low-resource hospitals.

After his experiences working and volunteering in Vietnam and Indonesia, he recognized that providing training for surgeons was not effective without also supplying the orthopaedic instruments and implants needed to use that knowledge.

The SIGN System enables surgeons to provide better more reliable healing and faster recovery from a fracture than they could using traction. [1] One independent study shows that SIGN’s implants provide the same outcome as the gold standard for femoral shaft fractures, at a lower price for patients. [2]

Education

SIGN partners with surgeons based in LMIC by providing orthopaedic education opportunities. SIGN hosts an annual conference for international surgeons, and supports regional conferences and trainings around the world. In addition, mentor surgeons provide feedback on every surgery after reviewing x-rays and case notes submitted to the SIGN Surgical Database. SIGN also partners with medical schools in LMIC to support their orthopaedic residency programs, with the goal of increasing the number of qualified surgeons in their home countries.

Medical Device Manufacturing

Intramedullary (IM) nails

Standard SIGN IM Nail

SIGN designs, manufactures, and donates intramedullary nails used to treat fractures in the femur, tibia, and humerus. The SIGN Nail is a solid, stainless-steel rod inserted into the canal of a fractured bone and stabilized with screws on each end. They are produced in a variety of lengths to allow surgeons to treat fractures for optimal results based on patient presentation.

SIGN Fin Nail

A design variant called the SIGN Fin Nail does not require interlocking screws at the distal end, using instead the friction of flanged fins to lock into the bone canal. This has been shown to make surgery simpler and significantly faster.

SIGN Pediatric Fin Nail

SIGN’s Pediatric Fin Nail uses the fin design, but is scaled to fit in the bones of younger patients and avoids using screws in growth centers of the bone, allowing the patient to grow during healing and avoiding long-term complications.

SIGN Instrument System

Orthopaedic Instruments

SIGN manufactures a system of orthopaedic instruments used to insert the nail and stabilize it with interlocking screws. This system does not rely on live-view C-arm x-ray systems in the operating room, as most commercially available implants do. Instead, SIGN’s Target Arm and Slot Finder guide insertion of the nail and accurately positioning screws for stabilization.

The SIGN System can be used without electricity, making it possible to perform surgery in austere conditions, including after natural disasters or in conflict regions. This is notable, as the World Health Organization estimates nearly 1 billion people are served by healthcare facilities that lack reliable access to electricity. [3]

Manufacturing Compliance

SIGN Fracture Care is registered with the United States Food and Drug Administration. SIGN manufactures finished medical devices in compliance with the United States Code of Federal Regulations, FDA Quality System Regulation ( 21CFR820) and maintains a quality management system that is certified to be compliant with ISO 13485:2016.

Patents Held

SIGN Instruments and Implants patented with the United States Patent and Trademarks Office include:

Current Non-profit Operations

Through contributions from individuals and foundations, SIGN donates education, instruments, and implants at no cost to hospitals or patients. In some cases, hospitals and distributors purchase implants at or below production cost.

As of November 2023, SIGN partners with more than 7,000 surgeons at 420 hospitals in 57 countries. Surgeons trained by SIGN have cared for more than 420,000 patients with fractures since 1999, and provide surgery for around 30,000 patients per year.

Low- and Middle-Income Countries with Active SIGN Programs by Region

Africa
Country # of Programs Active Since
Angola 1 2013
Benin 1 2021
Burkina Faso 1 2022
Burundi 7 2010
Cameroon 6 2007
Chad 4 2012
Dem. Rep. of the Congo 5 2012
Ethiopia 45 2009
Gabonese Republic 1 2010
Ghana 4 2014
Guinea 2 2019
Kenya 17 2007
Lesotho 1 2022
Liberia 4 2007
Madagascar 1 2020
Malawi 6 2007
Mali 1 2016
Niger 2 2007
Nigeria 17 2007
Rwanda 5 2007
Sierra Leone 2 2009
Somalia 2 2021
Somaliland 4 2019
South Sudan 3 2012
Tanzania 34 2007
The Gambia 1 2017
Togo 1 2014
Uganda 9 2010
Zambia 1 2013
Zimbabwe 6 2012
Americas
Country # of Programs Active Since
Dominican Republic 4 2007
Ecuador 3 2007
Haiti 15 2007
Honduras 2 2016
Nicaragua 2 2007
Peru 2 2007
Saint Lucia 1 2007
Venezuela 1 2019
Asia
Country # of Programs Active Since
Afghanistan 21 2007
Armenia 3 2020
Bangladesh 7 2007
Bhutan 1 2007
Cambodia 17 2007
India 1 2007
Indonesia 3 2007
Iraq 2 2007
Lao PDR 4 2012
Mongolia 2 2008
Myanmar 16 2007
Nepal 10 2007
Pakistan 8 2007
The Philippines 10 2007
Vietnam 1 2007
Yemen 1 2021
Oceania
Country # of Programs Active Since
Papua New Guinea 1 2018
Solomon Islands 1 2014
Europe
Country # of Programs Active Since
Ukraine 13 2022

Non-profit Industry Accreditation

References

  1. ^ Parkes, Rebekah J; Parkes, Gary; James, Kyle (19 May 2017). "A systematic review of cost-effectiveness, comparing traction to intramedullary nailing of femoral shaft fractures, in the less economically developed context". BMJ Global Health. 2 (3): e000313. doi: 10.1136/bmjgh-2017-000313. ISSN  2059-7908 – via NCBI.
  2. ^ Panti, Juan Paulo L.; Geronilla, Mario; Arada, Ernesto Carlo (October 23, 2013). "Clinical outcomes of patients with isolated femoral shaft fractures treated with S.I.G.N interlock nails versus Cannulated Interlock Intramedullary nails". Journal of Orthopaedics. 10 (4): 182–187. doi: 10.1016/j.jor.2013.09.003. ISSN  0972-978X.
  3. ^ "Close to one billion people globally are served by health-care facilities with no electricity access or with unreliable electricity". www.who.int. Retrieved 2023-11-14.
  4. ^ "Charity Ratings and Donor Resources". Charity Navigator. Retrieved 2023-11-15.
  5. ^ "SIGN Fracture Care International charity review & reports by Give.org". Give.org | BBB Wise Giving Alliance. Retrieved 2023-11-15.
  6. ^ "SIGN Fracture Care International - GuideStar Profile". www.guidestar.org. Retrieved 2023-11-15.
From Wikipedia, the free encyclopedia
SIGN Fracture Care
SIGN Fracture Care International
NicknameSIGN
FoundedJanuary 29, 1999; 25 years ago (1999-01-29)
FounderDr. Lewis G. Zirkle, Jr., President
Type Non-Profit Organization
501(c)(3)
91-1952283
PurposeBuilding orthopaedic capacity in LMIC by providing orthopaedic education and medical device design, manufacture, and donation of implants.
HeadquartersRichland, Washington, U.S.
Region
Global
Chief Executive Officer
Jeanne Dillner
Budget (2022)
US$ 8,340,000
Revenue (2022)
US$ 7,838,000
Expenses (2022)US$ 8,534,000
Staff (2023)
41
Website https://signfracturecare.org
Formerly called
Surgical Implant Generation Network

Overview

SIGN Fracture Care (SIGN) is a 501(c)(3) non-profit organization equipping orthopaedic surgeons in low-and middle-income countries (LMIC). It was founded in 1999 by Dr. Lewis G. Zirkle, Jr. to help surgeons care for patients with a fractured long bone.

SIGN’s vision is to create equality of fracture care throughout the world. [1]

SIGN empowers doctors in impoverished countries to improve the quality of care they can provide for patients with bone fractures. The SIGN Model is to provide ongoing educational support for LMIC surgeons, then donate the orthopaedic instruments and implants the surgeons need to care for patients with broken bones.

SIGN’s founder invented and patented a system of orthopaedic instruments and implants designed for use in low-resource hospitals.

After his experiences working and volunteering in Vietnam and Indonesia, he recognized that providing training for surgeons was not effective without also supplying the orthopaedic instruments and implants needed to use that knowledge.

The SIGN System enables surgeons to provide better more reliable healing and faster recovery from a fracture than they could using traction. [1] One independent study shows that SIGN’s implants provide the same outcome as the gold standard for femoral shaft fractures, at a lower price for patients. [2]

Education

SIGN partners with surgeons based in LMIC by providing orthopaedic education opportunities. SIGN hosts an annual conference for international surgeons, and supports regional conferences and trainings around the world. In addition, mentor surgeons provide feedback on every surgery after reviewing x-rays and case notes submitted to the SIGN Surgical Database. SIGN also partners with medical schools in LMIC to support their orthopaedic residency programs, with the goal of increasing the number of qualified surgeons in their home countries.

Medical Device Manufacturing

Intramedullary (IM) nails

Standard SIGN IM Nail

SIGN designs, manufactures, and donates intramedullary nails used to treat fractures in the femur, tibia, and humerus. The SIGN Nail is a solid, stainless-steel rod inserted into the canal of a fractured bone and stabilized with screws on each end. They are produced in a variety of lengths to allow surgeons to treat fractures for optimal results based on patient presentation.

SIGN Fin Nail

A design variant called the SIGN Fin Nail does not require interlocking screws at the distal end, using instead the friction of flanged fins to lock into the bone canal. This has been shown to make surgery simpler and significantly faster.

SIGN Pediatric Fin Nail

SIGN’s Pediatric Fin Nail uses the fin design, but is scaled to fit in the bones of younger patients and avoids using screws in growth centers of the bone, allowing the patient to grow during healing and avoiding long-term complications.

SIGN Instrument System

Orthopaedic Instruments

SIGN manufactures a system of orthopaedic instruments used to insert the nail and stabilize it with interlocking screws. This system does not rely on live-view C-arm x-ray systems in the operating room, as most commercially available implants do. Instead, SIGN’s Target Arm and Slot Finder guide insertion of the nail and accurately positioning screws for stabilization.

The SIGN System can be used without electricity, making it possible to perform surgery in austere conditions, including after natural disasters or in conflict regions. This is notable, as the World Health Organization estimates nearly 1 billion people are served by healthcare facilities that lack reliable access to electricity. [3]

Manufacturing Compliance

SIGN Fracture Care is registered with the United States Food and Drug Administration. SIGN manufactures finished medical devices in compliance with the United States Code of Federal Regulations, FDA Quality System Regulation ( 21CFR820) and maintains a quality management system that is certified to be compliant with ISO 13485:2016.

Patents Held

SIGN Instruments and Implants patented with the United States Patent and Trademarks Office include:

Current Non-profit Operations

Through contributions from individuals and foundations, SIGN donates education, instruments, and implants at no cost to hospitals or patients. In some cases, hospitals and distributors purchase implants at or below production cost.

As of November 2023, SIGN partners with more than 7,000 surgeons at 420 hospitals in 57 countries. Surgeons trained by SIGN have cared for more than 420,000 patients with fractures since 1999, and provide surgery for around 30,000 patients per year.

Low- and Middle-Income Countries with Active SIGN Programs by Region

Africa
Country # of Programs Active Since
Angola 1 2013
Benin 1 2021
Burkina Faso 1 2022
Burundi 7 2010
Cameroon 6 2007
Chad 4 2012
Dem. Rep. of the Congo 5 2012
Ethiopia 45 2009
Gabonese Republic 1 2010
Ghana 4 2014
Guinea 2 2019
Kenya 17 2007
Lesotho 1 2022
Liberia 4 2007
Madagascar 1 2020
Malawi 6 2007
Mali 1 2016
Niger 2 2007
Nigeria 17 2007
Rwanda 5 2007
Sierra Leone 2 2009
Somalia 2 2021
Somaliland 4 2019
South Sudan 3 2012
Tanzania 34 2007
The Gambia 1 2017
Togo 1 2014
Uganda 9 2010
Zambia 1 2013
Zimbabwe 6 2012
Americas
Country # of Programs Active Since
Dominican Republic 4 2007
Ecuador 3 2007
Haiti 15 2007
Honduras 2 2016
Nicaragua 2 2007
Peru 2 2007
Saint Lucia 1 2007
Venezuela 1 2019
Asia
Country # of Programs Active Since
Afghanistan 21 2007
Armenia 3 2020
Bangladesh 7 2007
Bhutan 1 2007
Cambodia 17 2007
India 1 2007
Indonesia 3 2007
Iraq 2 2007
Lao PDR 4 2012
Mongolia 2 2008
Myanmar 16 2007
Nepal 10 2007
Pakistan 8 2007
The Philippines 10 2007
Vietnam 1 2007
Yemen 1 2021
Oceania
Country # of Programs Active Since
Papua New Guinea 1 2018
Solomon Islands 1 2014
Europe
Country # of Programs Active Since
Ukraine 13 2022

Non-profit Industry Accreditation

References

  1. ^ Parkes, Rebekah J; Parkes, Gary; James, Kyle (19 May 2017). "A systematic review of cost-effectiveness, comparing traction to intramedullary nailing of femoral shaft fractures, in the less economically developed context". BMJ Global Health. 2 (3): e000313. doi: 10.1136/bmjgh-2017-000313. ISSN  2059-7908 – via NCBI.
  2. ^ Panti, Juan Paulo L.; Geronilla, Mario; Arada, Ernesto Carlo (October 23, 2013). "Clinical outcomes of patients with isolated femoral shaft fractures treated with S.I.G.N interlock nails versus Cannulated Interlock Intramedullary nails". Journal of Orthopaedics. 10 (4): 182–187. doi: 10.1016/j.jor.2013.09.003. ISSN  0972-978X.
  3. ^ "Close to one billion people globally are served by health-care facilities with no electricity access or with unreliable electricity". www.who.int. Retrieved 2023-11-14.
  4. ^ "Charity Ratings and Donor Resources". Charity Navigator. Retrieved 2023-11-15.
  5. ^ "SIGN Fracture Care International charity review & reports by Give.org". Give.org | BBB Wise Giving Alliance. Retrieved 2023-11-15.
  6. ^ "SIGN Fracture Care International - GuideStar Profile". www.guidestar.org. Retrieved 2023-11-15.

Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook